Item 9 Labs Corp (INLB)
US Market

Item 9 Labs (INLB) Income Statement


Item 9 Labs Income Statement

Last quarter (Q3 2023), Item 9 Labs's total revenue was $5.02M, an increase of 1.85% from the same quarter last year. In Q3, Item 9 Labs's net income was $-5.92M. See Item 9 Labs’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
$ 19.69M$ 21.76M$ 21.94M$ 8.12M$ 4.93M$ 1.38M
Cost of Revenue
$ 1.23M$ -14.45M$ 13.32M$ 4.83M$ 2.56M$ 1.02M
Gross Profit
$ 9.80M$ 7.31M$ 8.61M$ 3.30M$ 2.38M$ 357.19K
Operating Expense
$ 1.57M$ -30.38M$ 14.21M$ 8.62M$ 6.76M$ 1.05M
Operating Income
$ 3.87M$ -13.12M$ -5.60M$ -5.33M$ -4.38M$ -691.43K
Net Non Operating Interest Income Expense
$ -9.20M$ -15.95M$ -5.30M$ -6.96M$ -271.34K$ 27.87K
Other Income Expense
$ -11.63M$ 1.69M$ 9.16K$ -99.99K$ -5.30M-
Pretax Income
$ -17.12M$ -31.17M$ -10.91M$ -12.39M$ -9.95M$ -663.56K
Tax Provision
$ 3.96K$ 13.22K$ -2.28M$ -85.98K$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -17.09M$ -31.14M$ -10.91M$ -12.27M$ -9.82M$ -642.28K
Basic EPS
$ -0.32$ -0.33$ -0.14$ -0.20$ -0.16$ -0.20
Diluted EPS
$ -0.32$ -0.33$ -0.14$ -0.20$ -0.16$ -0.20
Basic Average Shares
$ 398.50M$ 95.69M$ 78.59M$ 61.62M$ 61.53M$ 2.74M
Diluted Average Shares
$ 398.50M$ 95.69M$ 78.59M$ 61.62M$ 61.53M$ 2.74M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 2.81M$ -44.82M$ 27.54M$ 13.45M$ 9.32M$ 2.07M
Net Income From Continuing And Discontinued Operation
$ -31.03M$ -31.14M$ -10.91M$ -12.27M$ -9.82M$ -642.28K
Normalized Income
$ -24.20M--$ -12.17M$ -4.07M$ -663.56K
Interest Expense
$ 2.48M--$ 6.96M$ 342.72K$ 1.99K
$ -7.92M$ -15.22M$ -5.61M$ -5.43M$ -9.61M$ -661.57K
$ -4.44M$ -13.61M$ -4.52M$ -4.45M$ -8.93M$ -611.79K
Currency in USD

Item 9 Labs Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis